The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to ...

As shares of Boston-based Vertex shot higher on the news of its non-opioid pill, Journavx, we took a look at investment in ...

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

Chronic pain affects approximately 1 in 5 Americans, and yet it remains one of the most misunderstood and challenging medical ...

Despite an increase in the use of medication for opioid use disorder in older adults from 2017 to 2022, disparities persist; ...

If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

FDA approves new type of non-opioid pain medication in two decades - The new drug will be many times more expensive than a ...

People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...

Navega Therapeutics, a biotechnology company developing epigenetic gene therapies, today announced the receipt of a $4M ...